Analyst Recommendations

Scotiabank analyst issues OUTPERFORM recommendation for CCJ on April 9, 2024 08:48AM ET. The previous analyst recommendation was Outperform.CCJ was trading at $47.9699 at issue of the analyst...

April 9, 2024   CCJ -4.73%

Scotiabank analyst issues SECTOR PERFORM recommendation for ERO on April 9, 2024 08:52AM ET. The previous analyst recommendation was Sector Perform.ERO was trading at $21.71 at issue of...

April 9, 2024   ERO -2.56%

Citigroup analyst issues BUY recommendation for OVV on April 9, 2024 08:43AM ET. The previous analyst recommendation was Buy.OVV was trading at $55.48 at issue of the analyst...

April 9, 2024   OVV -0.42%

B. Riley analyst issues BUY recommendation for TGLS on April 9, 2024 08:43AM ET. The previous analyst recommendation was Buy.TGLS was trading at $58.065 at issue of the...

April 9, 2024   TGLS -0.84%

Scotiabank analyst issues OUTPERFORM recommendation for TECK on April 9, 2024 09:03AM ET. The previous analyst recommendation was Outperform.TECK was trading at $48.56 at issue of the analyst...

April 9, 2024   TECK -4.19%

Scotiabank analyst issues OUTPERFORM recommendation for HBM on April 9, 2024 08:58AM ET. The previous analyst recommendation was Outperform.HBM was trading at $7.92 at issue of the analyst...

April 9, 2024   HBM 0.46%

Scotiabank analyst issues SECTOR PERFORM recommendation for FQVLF on April 9, 2024 08:57AM ET. The previous analyst recommendation was Sector Perform.FQVLF was trading at $11.45 at issue of...

April 9, 2024   FQVLF -0.94%

Scotiabank analyst issues OUTPERFORM recommendation for FCX on April 9, 2024 08:57AM ET. The previous analyst recommendation was Outperform.FCX was trading at $51.51 at issue of the analyst...

April 9, 2024   FCX -1.51%

Jefferies analyst issues BUY recommendation for STAA on April 9, 2024 08:57AM ET. The previous analyst recommendation was Buy.STAA was trading at $50.87 at issue of the analyst...

April 9, 2024   STAA -2.27%

Scotiabank analyst issues OUTPERFORM recommendation for IVPAF on April 9, 2024 09:00AM ET. The previous analyst recommendation was Outperform.IVPAF was trading at $13 at issue of the analyst...

April 9, 2024   IVPAF -2.86%